Loading...
Loading...
India's omeprazole imports from UNITED STATES total $654.5K across 256 shipments from 15 foreign suppliers. AMSTERDAM PHARMA(APTEKA RX INC.) leads with $173.7K in import value; the top 5 suppliers together control 52.8% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for omeprazole — a diversified sourcing base with multiple active suppliers from UNITED STATES.

AMSTERDAM PHARMA(APTEKA RX INC.) is the leading Omeprazole supplier from UNITED STATES to India, with import value of $173.7K across 27 shipments. The top 5 suppliers — AMSTERDAM PHARMA(APTEKA RX INC.), ESPEE BIOPHARMA & FINECHEM LLC, GRANULES PHARMACEUTICALS INC, SUN PHARMACEUTICAL INDUSTRIES INC., NILSCH LLC — collectively account for 52.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AMSTERDAM PHARMA(APTEKA RX INC.) | $173.7K | 27 | 26.5% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $59.1K | 6 | 9.0% |
| 3 | GRANULES PHARMACEUTICALS INC | $44.7K | 11 | 6.8% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES INC. | $36.8K | 7 | 5.6% |
| 5 | NILSCH LLC | $31.6K | 2 | 4.8% |
| 6 | NEW LIFE MEDICALS (USA), INC | $29.8K | 1 | 4.6% |
| 7 | AGRACE PHARMA. | $27.0K | 8 | 4.1% |
| 8 | AGRACE PHARMA | $26.7K | 5 | 4.1% |
| 9 | Espee Biopharma & Finechem LLC | $25.3K | 3 | 3.9% |
| 10 | RAFF & HALL PHARMACY | $23.9K | 17 | 3.7% |
| 11 | NEWLIFE MEDICAL(USA)INC | $16.6K | 6 | 2.5% |
| 12 | M/S.RAFF & HALL PHARMACY | $14.6K | 1 | 2.2% |
| 13 | AZURITY PHARMACEUTICALS | $12.6K | 4 | 1.9% |
| 14 | AMSTERDAM PHARMA | $11.2K | 1 | 1.7% |
| 15 | NEW LIFE MEDICALS (USA) INC. | $10.2K | 10 | 1.6% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LIMITED | $166.5K | 6 | 25.4% |
| 2 | DR.REDDY'S LABORATORIES LTD | $82.9K | 48 | 12.7% |
| 3 | GRANULES INDIA LIMITED | $45.2K | 12 | 6.9% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $38.9K | 10 | 5.9% |
| 5 | HETERO LABS LIMITED | $30.0K | 5 | 4.6% |
| 6 | SUSHEN MEDICAMENTOS PRIVATE LIMITED | $29.8K | 1 | 4.6% |
| 7 | AUROBINDO PHARMA LTD | $25.7K | 12 | 3.9% |
| 8 | AJANTA PHARMA LIMITED | $23.6K | 3 | 3.6% |
| 9 | INTAS PHARMACEUTICALS LTD | $23.3K | 3 | 3.6% |
| 10 | MICRO LABS LIMITED | $22.3K | 10 | 3.4% |
| 11 | ALEMBIC PHARMACEUTICALS LIMITED | $21.8K | 8 | 3.3% |
| 12 | HETERO LABS LIMITED | $16.3K | 2 | 2.5% |
| 13 | MANKIND PHARMA LIMITED | $15.8K | 16 | 2.4% |
| 14 | CLIANTHA RESEARCH LIMITED | $15.4K | 3 | 2.4% |
| 15 | AXXELENT PHARMA SCIENCE PRIVATE LIMITED | $14.2K | 11 | 2.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Omeprazole suppliers from UNITED STATES to India include AMSTERDAM PHARMA(APTEKA RX INC.), ESPEE BIOPHARMA & FINECHEM LLC, GRANULES PHARMACEUTICALS INC. The leading supplier is AMSTERDAM PHARMA(APTEKA RX INC.) with import value of $173.7K USD across 27 shipments. India imported Omeprazole worth $654.5K USD from UNITED STATES in total across 256 shipments.
India imported Omeprazole worth $654.5K USD from UNITED STATES across 256 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Omeprazole sourced from UNITED STATES include DR.REDDY'S LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, GRANULES INDIA LIMITED. The largest buyer is DR.REDDY'S LABORATORIES LIMITED with $166.5K in imports across 6 shipments.
The total value of Omeprazole imports from UNITED STATES to India is $654.5K USD, across 256 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
256 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists